Form 8-K - Current report:
SEC Accession No. 0001181431-12-058861
Filing Date
2012-11-15
Accepted
2012-11-15 17:13:08
Documents
2
Period of Report
2012-11-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rrd360599.htm 8-K 12803
2 PRESS RELEASE, DATED NOVEMBER 15, 2012, TITLED "DYNAVAX ANNOUNCES FDA ADVISORY C rrd360599_38797.htm EX-99 5335
  Complete submission text file 0001181431-12-058861.txt   19240
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 121209509
SIC: 2834 Pharmaceutical Preparations